Yarrow Bioscience (YARW) Non-Current Assets (2016 - 2026)

Yarrow Bioscience (YARW) has reported Non-Current Assets for 11 consecutive years, with $78000.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Non-Current Assets fell 79.2% year-over-year to $78000.0; the trailing twelve-month figure through Jun 2026 stood at $78000.0 (down 79.2% YoY), and the FY2025 full-year result was $150000.0, down 93.92% from the prior year.
• Non-Current Assets eased to $78000.0 in Q2 2026 per YARW's latest filing, from $84000.0 in the prior quarter.
• Across five years, Non-Current Assets topped out at $3.7 million in Q1 2022 and bottomed at $78000.0 in Q2 2026.
• Historically, Non-Current Assets has averaged $1.9 million across 5 years, with a median of $2.0 million in 2023.
• The sharpest annual moves came in 2024 and 2026: Non-Current Assets surged 51.65% in 2024, then tumbled 94.44% in 2026.
• Over 5 years, Non-Current Assets stood at $2.5 million in 2022, then slumped by 30.65% to $1.7 million in 2023, then soared by 43.32% to $2.5 million in 2024, then sank by 93.92% to $150000.0 in 2025, then tumbled by 48.0% to $78000.0 in 2026.
• According to Business Quant data, Non-Current Assets over the past three periods registered $78000.0, $84000.0, and $150000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.